6P5M
Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent
History
Please read more about PDB versioning on our help page.
Version | Date | Type | |
1-0 | 2020-01-15 | Initial release | No files available. |
1-1 | 2020-02-26 | Database references | No files available. |
1-2 | 2023-10-11 | Data collection, Database references, Refinement description |